Illumina Responds to Positive Updates from Chinese Ministry of Commerce
Rhea-AI Summary
Illumina (NASDAQ: ILMN) said the Chinese Ministry of Commerce will lift the export ban that had been in place since March 4, 2025, with the ban ending on November 10, 2025. The company remains on China’s Unreliable Entities List (UEL), which continues to require government approval for instrument purchases.
Illumina described MOFCOM’s announcement as a positive step, said it will keep engaging with authorities, and confirmed no change to FY25 guidance following its Q3 2025 update.
Positive
- Export ban set to lift on November 10, 2025
- FY25 guidance unchanged after Q3 2025 earnings update
Negative
- Still listed on China's Unreliable Entities List, requiring approvals
- Export ban had been in effect since March 4, 2025, limiting access
News Market Reaction
On the day this news was published, ILMN declined 1.09%, reflecting a mild negative market reaction. Our momentum scanner triggered 10 alerts that day, indicating notable trading interest and price volatility. This price movement removed approximately $212M from the company's valuation, bringing the market cap to $19.23B at that time.
Data tracked by StockTitan Argus on the day of publication.
Illumina remains focused on achieving a positive resolution regarding its inclusion on the UEL and is committed to serving customers in this important market. For two decades, Illumina has been proud to partner with customers in
"We are pleased with the announcement from MOFCOM, which is a very positive step forward. Illumina will continue to engage with authorities and stakeholders as we work toward a long-term resolution," said Jacob Thaysen, CEO of Illumina. "I want to thank our customers for their trust and support, and our team in
Illumina is making no change to FY25 guidance, which was recently updated during the company's Q3 2025 earnings call.
About Illumina
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit illumina.com and connect with us on X, Facebook, LinkedIn, Instagram, TikTok, and YouTube.
Contacts
Investors:
Illumina Investor Relations
858-291-6421
IR@illumina.com
Media:
Christine Douglass
PR@illumina.com
View original content:https://www.prnewswire.com/news-releases/illumina-responds-to-positive-updates-from-chinese-ministry-of-commerce-302606280.html
SOURCE Illumina, Inc.
FAQ
When will the export ban on Illumina (ILMN) be lifted in China?
Is Illumina (ILMN) still on China’s Unreliable Entities List (UEL)?
Will the MOFCOM announcement change Illumina's FY25 guidance (ILMN)?
What does lifting the export ban mean for Illumina (ILMN) customers in China?
When was the export ban on Illumina (ILMN) originally imposed by China?
How is Illumina (ILMN) responding to MOFCOM’s announcement?
